Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2014 1
2015 7
2016 5
2017 3
2018 7
2019 2
2020 1
2021 2
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
Kotseva K, Wood D, De Bacquer D, De Backer G, Rydén L, Jennings C, Gyberg V, Amouyel P, Bruthans J, Castro Conde A, Cífková R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Miličić D, Moore D, Nicolaides E, Oganov R, Pajak A, Pogosova N, Reiner Z, Stagmo M, Störk S, Tokgözoğlu L, Vulic D; EUROASPIRE Investigators. Kotseva K, et al. Among authors: gyberg v. Eur J Prev Cardiol. 2016 Apr;23(6):636-48. doi: 10.1177/2047487315569401. Epub 2015 Feb 16. Eur J Prev Cardiol. 2016. PMID: 25687109 Free article.
Oral glucose tolerance testing and cardiovascular disease.
Rydén L, Gyberg V, Schnell O, Tuomilehto J; EUROASPIRE IV investigators. Rydén L, et al. Among authors: gyberg v. Lancet Diabetes Endocrinol. 2016 Sep;4(9):732-733. doi: 10.1016/S2213-8587(16)30183-8. Lancet Diabetes Endocrinol. 2016. PMID: 27542923 No abstract available.
Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry.
Ferrannini G, De Bacquer D, Gyberg V, De Backer G, Kotseva K, Mellbin LG, Risebrink R, Tuomilehto J, Wood D, Rydén L. Ferrannini G, et al. Among authors: gyberg v. Diabetes Res Clin Pract. 2022 Jan;183:109156. doi: 10.1016/j.diabres.2021.109156. Epub 2021 Nov 26. Diabetes Res Clin Pract. 2022. PMID: 34843858
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.
Ferrannini G, De Bacquer D, Vynckier P, De Backer G, Gyberg V, Kotseva K, Mellbin L, Norhammar A, Tuomilehto J, Wood D, Rydén L; EUROASPIRE IV & V Investigators. Ferrannini G, et al. Among authors: gyberg v. Cardiovasc Diabetol. 2021 Feb 11;20(1):38. doi: 10.1186/s12933-021-01233-6. Cardiovasc Diabetol. 2021. PMID: 33573665 Free PMC article.
28 results